Core Medical Technology
Series D in 2025
Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.
DeepWise
Venture Round in 2025
Beijing DeepWise Science And Technology Co., Ltd. is a company that specializes in developing artificial intelligence-based medical application software aimed at enhancing clinical imaging analysis and diagnostics. Founded in 2017 and located in Beijing, China, DeepWise focuses on early screening and diagnosis of various malignant diseases, including lung and breast cancers. Its AI-driven software improves efficiency and diagnostic accuracy in healthcare, offering solutions to hospitals, medical centers, and imaging centers. The company's technology supports the online reading and consultation of medical images, leveraging big data in the cloud to facilitate timely and accurate disease detection and treatment.
TBSTest Technology is a Beijing-based company that develops, manufactures, and sells automatic test equipment for integrated circuits (IC). Founded in 2017, it specializes in research and development of ultra-large-scale integrated circuit test systems, primarily targeting enterprise users involved in IC design, production, packaging, and testing. The company's product offerings include test boards, software solutions, and memory systems, alongside comprehensive pre-sales and after-sales support for its equipment and accessories. TBSTest serves a diverse clientele, including scientific research institutions, universities, and various clients in the semiconductor industry. In addition to its headquarters in Beijing, the company has branch offices in Xi’an City and Shanghai, China, as well as in Suwon, South Korea.
DK Medtech
Series E in 2024
DK Medtech is a medical technology company based in Suzhou, China, specializing in the development and production of balloon catheter medical devices. Founded in 2015, the company has positioned itself as a leader in the medical device industry, focusing on innovative solutions to address complex healthcare challenges. Through its commitment to excellence, DK Medtech aims to improve patient outcomes and enhance the quality of healthcare.
Chaitin Tech
Venture Round in 2024
Beijing Chaitin Tech Co., Ltd. is a technology-oriented security company focused on addressing Internet security challenges. With a highly skilled research and development team, Chaitin Tech specializes in creating customized security products and services aimed at enhancing the security capabilities of enterprises. The company develops innovative web application security solutions that protect critical assets from evolving cyber threats. By leveraging advanced technologies and methods, Chaitin Tech strives to improve domestic security levels while aligning with global standards in cybersecurity.
Dearer Medical
Series C in 2024
Dearer Medical is a medical device company based in China that specializes in the development, production, and sales of eye-related products, particularly contact lenses. The company is dedicated to research and development in this field, focusing on both practical and fashionable color contact lens options. By combining innovation with quality manufacturing, Dearer Medical aims to meet the diverse needs of customers seeking enhanced vision solutions.
Leapstack
Series C in 2023
Leapstack is an insurance technology company founded in February 2016 and headquartered in Shanghai, with additional offices in Beijing and Nanjing. The company specializes in big data artificial intelligence solutions tailored for commercial insurance providers and social security management agencies. Leapstack develops a data analysis and management platform that enhances the insurance claims process by offering services such as risk control monitoring, post-medical reimbursement, and anti-fraud compliance identification. By addressing inefficiencies within the insurance industry, Leapstack aims to improve operational effectiveness and facilitate better decision-making for its clients.
Alioth specializes in the development and application of pharmaceutical process technology, focusing on high-quality separation and purification solutions for the pharmaceutical and biotechnology sectors. The company is committed to ensuring compliance with domestic and international regulations, particularly Good Manufacturing Practices (GMP). To support its operations, Alioth has established production facilities in Lingang, Shanghai, and Hangzhou, which house process development labs, verification labs, and research and development centers dedicated to filtration technology. The team, comprised of membrane technology scientists, plays a crucial role in advancing the company’s product offerings and enhancing supply chain security. Through its innovative solutions, Alioth aims to improve pharmaceutical manufacturing processes for its partners.
Ligatech Bioscience
Series D in 2023
Ligatech Bioscience, established in 2014 and headquartered in Qingpu, China, specializes in the design, development, production, and sales of medical devices for orthopedic and sports medicine. Its product portfolio includes molecular weight polyethylene suture and striped titanium plates, along with artificial ligaments and fixation systems. The company also offers technical advice and services to its users.
Alioth specializes in the development and application of pharmaceutical process technology, focusing on high-quality separation and purification solutions for the pharmaceutical and biotechnology sectors. The company is committed to ensuring compliance with domestic and international regulations, particularly Good Manufacturing Practices (GMP). To support its operations, Alioth has established production facilities in Lingang, Shanghai, and Hangzhou, which house process development labs, verification labs, and research and development centers dedicated to filtration technology. The team, comprised of membrane technology scientists, plays a crucial role in advancing the company’s product offerings and enhancing supply chain security. Through its innovative solutions, Alioth aims to improve pharmaceutical manufacturing processes for its partners.
GalaxySpace
Series D in 2022
GalaxySpace is a Chinese company established in 2016, specializing in the development and manufacturing of low Earth orbit (LEO) broadband satellite constellations and 5G communication networks. The company focuses on creating satellite internet solutions and is engaged in the research, development, and production of various communication payloads and satellite platforms. Its product offerings include microwave communication payloads, phased array antennas, power management systems, and solar panels. Additionally, GalaxySpace provides comprehensive AI-driven satellite launch services, enabling clients to access efficient communication and information services at lower costs. The company's satellite applications extend to monitoring airport traffic, parking, and oil reserves, as well as evaluating land types and uses.
Shuhai Supply Chain
Series B in 2022
Shuhai Supply Chain Logistics is a leading supply chain service provider based in Beijing, China, established in June 2011. The company specializes in offering comprehensive supply chain solutions tailored for the food industry, particularly catering businesses. Its services encompass sales, procurement, production, quality assurance, warehousing, and transportation, ensuring that restaurant owners receive fresh and high-quality ingredients. Shuhai operates a nationwide modern cold chain logistics network and food processing plants, which positions it as a benchmark enterprise in the supply chain sector, recognized by both industry authorities and customers for its commitment to quality and reliability.
Nuclei System Technology
Venture Round in 2022
Nuclei System Technology is a pioneering semiconductor company in China that specializes in RISC-V processor licensing. The company focuses on the development of high-performance and low-power processors, along with associated system-on-chip (SoC) platforms, tailored for a wide range of embedded system applications. Nuclei's innovative semiconductor solutions are designed for smart electronics, telecommunications, and computer processing, particularly in the context of artificial intelligence of things (AIoT) applications. By offering configurable 32/64-bit RISC-V processors, Nuclei aims to meet the increasing demands of the global market for advanced and efficient embedded technologies.
APTBIO was initiated by Shanghai Institutes for Biological Sciences under Chinese Academy of Sciences in 2004, and is mainly engaged in the application of mass spectrometry technology. The so-called mass spectrometry technology is to measure the quality of protein molecules to carry out the identification of protein molecules, the modification of protein molecules and the study of protein molecule interactions.
TBSTest
Venture Round in 2022
TBSTest Technology is a Beijing-based company that develops, manufactures, and sells automatic test equipment for integrated circuits (IC). Founded in 2017, it specializes in research and development of ultra-large-scale integrated circuit test systems, primarily targeting enterprise users involved in IC design, production, packaging, and testing. The company's product offerings include test boards, software solutions, and memory systems, alongside comprehensive pre-sales and after-sales support for its equipment and accessories. TBSTest serves a diverse clientele, including scientific research institutions, universities, and various clients in the semiconductor industry. In addition to its headquarters in Beijing, the company has branch offices in Xi’an City and Shanghai, China, as well as in Suwon, South Korea.
Senscomm Semiconductor
Series A in 2022
Senscomm Semiconductor Co., Ltd. is a fabless semiconductor company established in 2018 and headquartered in Suzhou, China. The company specializes in the design and development of semiconductor solutions, focusing on key technology areas such as augmented reality (AR), virtual reality (VR), the Internet of Things (IoT), and electric vehicles (EV). Since its inception, Senscomm has successfully launched over 20 products, addressing the growing global demand for innovative semiconductor technologies in these rapidly evolving markets.
Fit2Cloud
Series D in 2022
Fit2Cloud, established in 2014, is a prominent provider of Multi-Cloud Management Platform solutions in China. The company focuses on enhancing the cloud management experience for enterprise customers across various multi-cloud environments. Fit2Cloud's offerings address critical issues related to IT operation security and continuous application delivery. Their product lineup includes a comprehensive Cloud Management Platform, JumpServer (an open-source fortress machine), DataEase (an open-source data visualization and analysis platform), and MeterSphere (an open-source continuous testing platform). Through these solutions, Fit2Cloud empowers enterprises to effectively manage and utilize cloud services, facilitating their digital transformation and ensuring a seamless operational experience.
MediLink Therapeutics
Series B in 2022
MediLink Therapeutics is a biotechnology company with a research and development center located in Suzhou, China. The company specializes in the development of next-generation antibody-drug conjugates (ADCs) aimed at treating cancer more effectively. MediLink Therapeutics is dedicated to addressing significant unmet medical needs within China and seeks to create global value through multicenter clinical trials and cross-border collaborations. By focusing on ADC therapeutics, the company aims to provide cancer patients with treatments that target cancerous cells while minimizing harm to healthy cells, thereby enhancing patient well-being during treatment.
Inceptio Technology
Series B in 2022
Inceptio Technology is a developer of autonomous driving heavy-duty trucks based in Shanghai, China, with additional research and development centers in Silicon Valley. Founded in 2018, the company aims to transform line-haul logistics by offering a nationwide freight network that enhances safety, efficiency, and cost-effectiveness for logistic customers. Its autonomous trucks leverage advanced artificial intelligence, new energy technology, and logistics big data to deliver innovative and reliable transportation solutions. By focusing on the integration of these technologies, Inceptio Technology is positioned to provide significant improvements in the logistics sector.
Hong Kong Asia Heart Centre
Series D in 2022
Hong Kong Asia Heart Centre is a cardiovascular specialist chain that provides various cardiovascular assessment and surgical services. Founded in 1999, The Hong Kong Asian Heart Center has a professional medical team with many years of experience in the treatment of heart disease.
Hoteam Software
Series C in 2022
Hoteam Software specializes in developing and implementing enterprise-level intelligent manufacturing solutions, primarily focusing on independent research and development of industrial software tailored for Chinese markets. The company offers a suite of services including CAD, CAM, CAPP, PDM, PLM, MES, WMS, SRM, and digital factory solutions, all centered around 3D software. Their platforms aim to enhance work efficiency and reduce costs for industrial enterprises by providing collaborative research and development opportunities.
Zshield Inc. is a Beijing-based company specializing in cyberspace data security and big data business risk management. Established in 2014, it is recognized as the first high-tech firm in China to leverage big data technologies in addressing emerging information security vulnerabilities. Zshield develops advanced integrated information security solutions that utilize lightweight virtualization, deep learning, and big data analysis to provide effective monitoring of server and terminal security. Its offerings include a comprehensive information security platform and the AndunTM ZS-ISP, which supports both government and enterprise clients in navigating the complexities of modern computing environments, including cloud computing and mobile applications. As traditional security measures struggle to cope with new threats, Zshield's innovative approach aims to fortify businesses against the evolving landscape of information security challenges.
Leapstack
Series C in 2021
Leapstack is an insurance technology company founded in February 2016 and headquartered in Shanghai, with additional offices in Beijing and Nanjing. The company specializes in big data artificial intelligence solutions tailored for commercial insurance providers and social security management agencies. Leapstack develops a data analysis and management platform that enhances the insurance claims process by offering services such as risk control monitoring, post-medical reimbursement, and anti-fraud compliance identification. By addressing inefficiencies within the insurance industry, Leapstack aims to improve operational effectiveness and facilitate better decision-making for its clients.
Xbiome Co. Ltd., established in 2017 and headquartered in Shenzhen, China, is an AI-based microbiome drug development company. It specializes in the analysis of patient and donor intestinal flora using artificial intelligence to accelerate the development of effective pharmaceuticals for microecological intestinal disorders. Xbiome's products focus on micro-ecological treatment, aiming to manage the gut health of a vast population.
ColorTech Bio
Series B in 2021
ColorTech Bio researches and develops precision molecular diagnostic equipment. It offers medical devices to improve biotechnology services and solutions. ColorTech Bio was founded in 2018 and is based in Suzhou, China.
River Security
Series C in 2021
River Security is a cybersecurity company that specializes in fraud risk protection and innovative dynamic application security solutions. Founded in 2012 and headquartered in Shanghai, with additional offices in Beijing and Shenzhen, the company has developed cutting-edge active defense security technology after extensive research and development. This technology challenges traditional security paradigms that have been in place for over two decades, enabling more effective and timely defenses against a wide range of modern cyber threats. River Security's products include a dynamic security bot-gate that predicts server behavior by transforming the underlying code of web pages, thereby enhancing the protection of corporate website applications and safeguarding business data. The company's approach not only improves security measures but also reduces deployment and operational costs for users.
ESWIN Computing
Series C in 2021
ESWIN Computing is a company specializing in the research and development of RISC-V computing architecture. It focuses on the design, testing, and material aspects of integrated circuits for Internet of Things (IoT) applications, particularly in display devices and wearable technology. ESWIN provides comprehensive solutions for various sectors, including artificial intelligence, the Internet of Vehicles, and human-computer interaction, aiming to enhance user experiences in these rapidly evolving fields.
Lunit
Venture Round in 2021
Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company focuses on developing solutions that aid physicians in making objective diagnoses through machine learning technology. Lunit's expertise encompasses various medical imaging fields, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. The company's products include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which provides AI-powered biomarkers for immuno-oncology. Lunit aims to enhance clinical decision-making by leveraging data-driven imaging biomarker technology, ultimately improving the accuracy and efficiency of cancer care. The effectiveness of Lunit's deep learning technology has been validated through its recognition in major image recognition competitions, showcasing its capacity to process complex medical imaging data.
Qixuan Technology
Series A in 2021
An AI & Robotics Company based in Shenzhen,China.
Wuxi Biortus Biosciences
Series B in 2021
Wuxi Biortus Biosciences Co. Ltd. is a contract research organization based in Jiangyin, China, founded in 2009. The company specializes in providing research and development services to facilitate drug discovery. Its offerings include recombinant protein production, in vitro assays and screening, medicinal chemistry, structural biology, and target validation. Wuxi Biortus operates five advanced research platforms, including X-ray crystallography and cryo-electron microscopy, aimed at delivering high-quality R&D services to clients. The organization is known for its innovative approaches, with several techniques developed by its research team receiving patents. Wuxi Biortus is a subsidiary of Jiangsu Shuangliang Group Company Ltd.
H.Extract
Series C in 2021
H.Extract is a company focused on research and development, promotion, and sales of pharmaceutical enterprise resource planning (ERP) solutions. As a leading brand in the domestic pharmaceutical distribution sector, H.Extract's Cloud ERP System, Romens, has established a significant presence, serving over 40,000 pharmacies across China. The company has formed strategic partnerships, notably with Tencent Cloud and WeChat Pay, to enhance the efficiency of the medicine distribution industry, particularly in pharmaceutical wholesale and chain drugstores. With 14 years of experience, H.Extract has developed a strong technical foundation and management expertise in the operation of chain drugstores, allowing it to expand its customer base to include major pharmaceutical entities such as Harbin Pharmaceutical Group and Sichuan Derentang.
LYNK Pharmaceuticals
Series B in 2021
LYNK Pharmaceuticals is a biotechnology company based in Hangzhou, China, specializing in the development of small molecule drugs aimed at treating tumors and autoimmune diseases. Founded in 2017, the company focuses on the discovery and development of innovative medicines in the fields of oncology, immunology, and inflammatory diseases. Its business operations include new drug research, sales, and activities related to patent authorization and transfer.
Berry Oncology
Series B in 2021
Berry Oncology specializes in developing genetic diagnostic solutions for early detection and mid-to-late stage monitoring of various malignant tumors. Their offerings span from companion diagnostics to response monitoring and prognosis prediction for both targeted and immune therapies, aiming to enhance cancer prevention and tumor diagnosis globally. The company's primary mission is to facilitate early diagnosis and treatment of all tumors, ensuring precise care for patients. Berry Oncology aspires to become a global leader in early screening and diagnosis of tumors, particularly in China's tumor gene testing market.
QANDA(Mathpresso)
Series C in 2021
Mathpresso, Inc. is an educational technology company based in Seoul, South Korea, established in 2015. It operates Qanda, a data-driven platform that leverages artificial intelligence and optical character recognition (OCR) technology to assist students with their studies. Users can take a photo of a question or problem, which the platform then analyzes to provide solutions and explanations. Qanda covers a wide range of subjects, including mathematics, Korean history, social studies, and science. The platform is designed to facilitate learning by allowing students to engage with tutors and access answers in real time. As of this year, Qanda has attracted over one million users in South Korea, making it a significant resource for students seeking help with homework and exam preparation.
Dearer Medical
Series B in 2021
Dearer Medical is a medical device company based in China that specializes in the development, production, and sales of eye-related products, particularly contact lenses. The company is dedicated to research and development in this field, focusing on both practical and fashionable color contact lens options. By combining innovation with quality manufacturing, Dearer Medical aims to meet the diverse needs of customers seeking enhanced vision solutions.
XSKY Data Technology
Series E in 2021
XSKY Data Technology, based in Beijing, specializes in software-defined infrastructure products and services. It offers a range of storage solutions, including XCBS (cloud), XEBS (block), XEUS (unified), XEOS (object), and XEDP (unified data platform), catering to diverse sectors such as finance, telecom, energy, and government. XSKY is a significant contributor to the open-source Ceph storage system, ranking top 3 globally. It partners with leading tech companies like Intel and Samsung, providing scalable, cost-effective storage solutions tailored for enterprise needs.
Liangyihui
Series C in 2021
Suzhou Liangyihui Network Technology Co., Ltd. is an authoritative anti-cancer academic platform based in Shanghai, China. The company focuses on addressing the information asymmetry prevalent in the oncology field by fostering long-term collaborations with various well-known hospitals and authoritative institutions both domestically and internationally. Liangyihui operates an online platform that provides comprehensive educational materials related to tumor treatment and oncology. This includes medical cases, conference information, online courses, and research reports, all aimed at offering reliable information and resources for oncologists, cancer researchers, and patients. The platform serves as a vital tool for promoting cancer prevention and treatment, thereby enhancing public awareness and understanding of cancer-related issues.
Exegenesis Bio
Series B in 2021
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.
MicuRx Pharmaceuticals
Series E in 2020
MicuRx Pharmaceuticals is a biopharmaceutical company focused on discovering and developing novel antibiotics to combat drug-resistant bacterial infections. Founded in 2007 and based in Palo Alto, California, MicuRx operates with research and development facilities in both San Francisco, California, and Shanghai, China. The company's portfolio includes MRX-I, an oral antibiotic effective against multi-drug resistant gram-positive pathogens such as methicillin-resistant staphylococcus aureus and vancomycin-resistant enterococci; MRX-IV, a water-soluble prodrug form of MRX-I for intravenous use; MRX-V, an injectable antibiotic targeting gram-negative bacteria; and MRX-VIII, a polymyxin for gram-negative infections. Additionally, MicuRx's pipeline includes other antibacterial drugs designed to combat both gram-positive and gram-negative bacterial pathogens. The company employs a hybrid U.S./China business model, leveraging U.S. research and development with cost-efficient scientific resources in China. Shanghai MicuRx commercializes the agent contezolid in China, while global clinical studies are ongoing.
Xbiome Co. Ltd., established in 2017 and headquartered in Shenzhen, China, is an AI-based microbiome drug development company. It specializes in the analysis of patient and donor intestinal flora using artificial intelligence to accelerate the development of effective pharmaceuticals for microecological intestinal disorders. Xbiome's products focus on micro-ecological treatment, aiming to manage the gut health of a vast population.
GalaxySpace
Series C in 2020
GalaxySpace is a Chinese company established in 2016, specializing in the development and manufacturing of low Earth orbit (LEO) broadband satellite constellations and 5G communication networks. The company focuses on creating satellite internet solutions and is engaged in the research, development, and production of various communication payloads and satellite platforms. Its product offerings include microwave communication payloads, phased array antennas, power management systems, and solar panels. Additionally, GalaxySpace provides comprehensive AI-driven satellite launch services, enabling clients to access efficient communication and information services at lower costs. The company's satellite applications extend to monitoring airport traffic, parking, and oil reserves, as well as evaluating land types and uses.
LYNK Pharmaceuticals
Series A in 2020
LYNK Pharmaceuticals is a biotechnology company based in Hangzhou, China, specializing in the development of small molecule drugs aimed at treating tumors and autoimmune diseases. Founded in 2017, the company focuses on the discovery and development of innovative medicines in the fields of oncology, immunology, and inflammatory diseases. Its business operations include new drug research, sales, and activities related to patent authorization and transfer.
Hemu (China) Biological Engineering
Series B in 2020
Hemu (China) Biological Engineering is a Chinese blood vessel intervention medical equipment firm.
Delova Biotech
Venture Round in 2020
Delova Biotech is a company dedicated to advancing pain treatment through the development of non-opioid analgesics. Leveraging extensive research and development experience, Delova Biotech focuses on enhancing existing drugs and creating innovative new analgesics in both China and the United States. The company employs advanced technology platforms, including long-acting injection technology, topical transdermal formulations, and nano-delivery systems, to improve drug efficacy. Additionally, Delova Biotech specializes in prodrug modification and enhancing solubility for insoluble drugs, aiming to deliver superior quality medications that enhance the quality of life for patients experiencing pain.
Exegenesis Bio
Seed Round in 2020
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.
Eswin specializes in integrated circuit (IC) application solutions across various sectors, including mobile devices, smart homes, smart transportation, and industrial IoT. The company manufactures 12-inch monocrystalline silicon polished and epitaxial wafers, which are essential for semiconductor production. Eswin is dedicated to optimizing advanced equipment and processes to produce high-quality, dislocation-free, ultra-flat silicon wafers, primarily utilized for logic chips, flash memory chips, dynamic random access memory (DRAM), image sensors, and display driver ICs. Additionally, Eswin offers rear-end IC packaging and testing services. The company operates research and development centers in China, the U.K., and South Korea, along with production facilities located in Xi'an, Chengdu, Hefei, and Suzhou.
Novast
Venture Round in 2020
Novast Holdings Ltd. is a multinational pharmaceutical company headquartered in China and the United States, specializing in the research, development, and manufacturing of FDA-inspected generic drugs. The company is recognized for its expertise in designing challenging formulations and drug delivery systems, focusing on value-added generics with controlled release and various dosage types. Novast collaborates with pharmaceutical and biotechnology firms to commercialize products for regulated markets, positioning itself as a key player in the U.S. pharmaceutical sector. With cGMP manufacturing facilities spanning 18,000 square meters, Novast has a management team experienced in applying numerous generic drug patents in the U.S. and possesses a strong foundation in innovative drug development technologies. Its unique capabilities in addressing diverse research, development, and manufacturing needs distinguish Novast within the industry.
TBSTest Technology is a Beijing-based company that develops, manufactures, and sells automatic test equipment for integrated circuits (IC). Founded in 2017, it specializes in research and development of ultra-large-scale integrated circuit test systems, primarily targeting enterprise users involved in IC design, production, packaging, and testing. The company's product offerings include test boards, software solutions, and memory systems, alongside comprehensive pre-sales and after-sales support for its equipment and accessories. TBSTest serves a diverse clientele, including scientific research institutions, universities, and various clients in the semiconductor industry. In addition to its headquarters in Beijing, the company has branch offices in Xi’an City and Shanghai, China, as well as in Suwon, South Korea.
Harbour BioMed
Series B in 2020
Harbour BioMed is a biotechnology company focused on discovering and developing therapeutics for cancer and inflammatory diseases. Established in 2016 with operations in Shanghai, Cambridge, and Rotterdam, the company leverages its proprietary transgenic mouse platforms to generate fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb), enabling the development of differentiated compounds such as bi-specific and multi-specific antibodies. Harbour BioMed collaborates strategically with various institutions and companies, including The Wistar Institute, WuXi Biologics, and Vir Biotechnology, to advance its pipeline of therapeutics targeting autoimmune diseases, dry eye disease, COVID-19, and other indications.
Shanghai Feiyu Network Technology Co., Ltd. operates a live e-commerce platform specializing in the trading of used luxury products, particularly handbags. The company conducts live broadcasts showcasing various luxury brand handbags through its mobile application, allowing users to view the products in real-time and make purchases at lower prices. In addition to handbags, Feiyu's platform includes a range of luxury items such as bags, accessories, watches, footwear, and clothing, catering to the growing market for pre-owned luxury goods in China.
Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company focuses on developing solutions that aid physicians in making objective diagnoses through machine learning technology. Lunit's expertise encompasses various medical imaging fields, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. The company's products include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which provides AI-powered biomarkers for immuno-oncology. Lunit aims to enhance clinical decision-making by leveraging data-driven imaging biomarker technology, ultimately improving the accuracy and efficiency of cancer care. The effectiveness of Lunit's deep learning technology has been validated through its recognition in major image recognition competitions, showcasing its capacity to process complex medical imaging data.
Suzhou Ribo Life Science
Series C in 2019
Suzhou Ribo Life Science Co., Ltd. is a biotechnology company specializing in the development of nucleic acid drugs based on RNA interference (RNAi) technology. Established in 2007 and located in Kunshan, China, the company focuses on various aspects of RNAi, including drug discovery, siRNA design and screening, chemical modification, delivery technology, pharmacodynamics/pharmacokinetics studies, safety evaluation, and clinical trials. Suzhou Ribo Life Science develops siRNA therapeutics targeting conditions such as Hepatitis B, breast carcinoma, liver fibrosis, liver carcinoma, and HIV. The company has formed a strategic partnership with Quark Pharmaceuticals, Inc. to enhance its capabilities in the field. Through its innovative approach, Suzhou Ribo Life Science aims to provide more effective pharmaceutical solutions for healthcare providers and patients.
Xbiome Co. Ltd., established in 2017 and headquartered in Shenzhen, China, is an AI-based microbiome drug development company. It specializes in the analysis of patient and donor intestinal flora using artificial intelligence to accelerate the development of effective pharmaceuticals for microecological intestinal disorders. Xbiome's products focus on micro-ecological treatment, aiming to manage the gut health of a vast population.
Gambol Pet Group
Series B in 2019
Gambol Pet Group Co., Ltd is a prominent manufacturer of pet food, specializing in a diverse array of products including dry and wet food, real meat jerky treats, rawhide chews, and dental bones. Founded in 2006 and headquartered in Liaocheng City, China, the company focuses on the research, development, production, and sales of various pet food categories. Its offerings encompass pet treats made from chicken, duck, pork, lamb, and fish, as well as dog food enriched with nutritional supplements and natural ingredients. Gambol Pet Group serves a wide customer base across Europe, Asia, and North America, demonstrating its international reach and commitment to quality in pet nutrition. The company is led by Chairman and CEO Qin Hua.
QANDA(Mathpresso)
Series B in 2019
Mathpresso, Inc. is an educational technology company based in Seoul, South Korea, established in 2015. It operates Qanda, a data-driven platform that leverages artificial intelligence and optical character recognition (OCR) technology to assist students with their studies. Users can take a photo of a question or problem, which the platform then analyzes to provide solutions and explanations. Qanda covers a wide range of subjects, including mathematics, Korean history, social studies, and science. The platform is designed to facilitate learning by allowing students to engage with tutors and access answers in real time. As of this year, Qanda has attracted over one million users in South Korea, making it a significant resource for students seeking help with homework and exam preparation.
Mancando is an automotive parts supplier based in Guangzhou, Guangdong, China, founded in August 2015. The company specializes in providing a comprehensive range of car wearing parts for auto repair factories. Its product portfolio includes essential components related to lubrication, braking, wiper systems, filtering, ignition, timing, and lighting, allowing customers to source all necessary automotive products from a single provider. Mancando employs an innovative approach to traditional auto parts management by integrating internet and platform management, enhancing the efficiency and accessibility of automotive parts for its clientele.
GalaxySpace
Series B in 2019
GalaxySpace is a Chinese company established in 2016, specializing in the development and manufacturing of low Earth orbit (LEO) broadband satellite constellations and 5G communication networks. The company focuses on creating satellite internet solutions and is engaged in the research, development, and production of various communication payloads and satellite platforms. Its product offerings include microwave communication payloads, phased array antennas, power management systems, and solar panels. Additionally, GalaxySpace provides comprehensive AI-driven satellite launch services, enabling clients to access efficient communication and information services at lower costs. The company's satellite applications extend to monitoring airport traffic, parking, and oil reserves, as well as evaluating land types and uses.
GKHT Medical Technology
Series C in 2019
Guoke Hengtai (Beijing) Medical Technology Co., Ltd. is a Chinese company established in February 2013 and headquartered in the Yizhuang Economic and Technological Development Zone of Beijing. It operates under the umbrella of Oriental Science and Technology Holding Group Co., Ltd., which is connected to the State-owned Assets Supervision and Administration Commission of the Chinese Academy of Sciences. GKHT Medical Technology specializes in the distribution and direct sales of medical devices, offering a range of professional services, including warehousing logistics, distribution channel management, and hospital SPD operation management. Since its inception, the company has demonstrated significant growth, achieving a compound annual growth rate of over 50%, and it is currently pursuing an initial public offering.
AgotoZ Technology, established in 2017, specializes in high-speed network transmission solutions for enterprises. The company, operating under Guanmai Technology (Beijing) Co., Ltd., focuses on developing advanced technologies in WAN transmission, big data computing, and security defense. AgotoZ aims to enhance enterprise performance by providing an efficient interoperability platform and related solutions, ensuring that businesses can effectively meet their network transmission needs. Through independent research and development, AgotoZ continues to innovate its core technologies and products, positioning itself as a leader in the field of intelligent network transmission.
Shuhai Supply Chain
Series B in 2019
Shuhai Supply Chain Logistics is a leading supply chain service provider based in Beijing, China, established in June 2011. The company specializes in offering comprehensive supply chain solutions tailored for the food industry, particularly catering businesses. Its services encompass sales, procurement, production, quality assurance, warehousing, and transportation, ensuring that restaurant owners receive fresh and high-quality ingredients. Shuhai operates a nationwide modern cold chain logistics network and food processing plants, which positions it as a benchmark enterprise in the supply chain sector, recognized by both industry authorities and customers for its commitment to quality and reliability.
Bondent Technology Co., Ltd., headquartered in Shanghai, China, specializes in supplying dental equipment and materials. It offers a comprehensive range of services, including technical training, operational and management consulting, decoration design, and financial solutions. Bondent's core business involves the design, development, manufacturing, and sales of oral medical equipment, creating a full ecosystem for the dental and oral health industry.
River Security
Series B in 2019
River Security is a cybersecurity company that specializes in fraud risk protection and innovative dynamic application security solutions. Founded in 2012 and headquartered in Shanghai, with additional offices in Beijing and Shenzhen, the company has developed cutting-edge active defense security technology after extensive research and development. This technology challenges traditional security paradigms that have been in place for over two decades, enabling more effective and timely defenses against a wide range of modern cyber threats. River Security's products include a dynamic security bot-gate that predicts server behavior by transforming the underlying code of web pages, thereby enhancing the protection of corporate website applications and safeguarding business data. The company's approach not only improves security measures but also reduces deployment and operational costs for users.
Zongmu Technology Co. Ltd, established in 2013, is a Shanghai-based company specializing in automotive industry solutions and integration services. It operates research and development centers in Beijing and Shenzhen. Zongmu is renowned for its SurroundView ADAS (Advanced Driving Assistance System), which has been successfully implemented in major OEM automotive markets. The company has formed strategic partnerships with several OEM car manufacturers and tier-1 suppliers, solidifying its position as the leading SurroundView ADAS solution provider in the Chinese domestic market.
Beijing DeepWise Science And Technology Co., Ltd. is a company that specializes in developing artificial intelligence-based medical application software aimed at enhancing clinical imaging analysis and diagnostics. Founded in 2017 and located in Beijing, China, DeepWise focuses on early screening and diagnosis of various malignant diseases, including lung and breast cancers. Its AI-driven software improves efficiency and diagnostic accuracy in healthcare, offering solutions to hospitals, medical centers, and imaging centers. The company's technology supports the online reading and consultation of medical images, leveraging big data in the cloud to facilitate timely and accurate disease detection and treatment.
New Horizon Health
Series C in 2019
New Horizon Health is a biotechnology company based in Hangzhou, China, with an additional office in Beijing, specializing in the development of innovative technologies for early cancer detection and screening. Founded in 2015, the company primarily focuses on gastrointestinal cancers, offering products such as the ColoClear and Pupu Tube, which utilize fecal gene analysis (FIT-DNA) technology for colorectal cancer screening. These products enable users to conduct in-home tests, allowing for the early detection of colon cancer and precancerous lesions that may not be identified through traditional blood tests. New Horizon Health aims to reduce cancer morbidity and mortality rates by promoting accessible and efficient health services, leveraging big data and artificial intelligence in its screening technologies. The company's commitment to early cancer screening reflects its mission to enhance public health by facilitating widespread access to vital diagnostic tools.
Neusoft Huiju
Series A in 2019
Beijing Neusoft Huiju Information Technology Co., Ltd. is an independent business unit of Neusoft and Donghua focusing on enterprise information solutions. The company was established in 2007 and currently has a staff of more than 1,000 people. Headquartered in Beijing, the company has six marketing centers, eight delivery centers, and three R&D centers across the country, as well as overseas operations in Japan and the United States.
Black Sesame Technologies
Series B in 2019
Black Sesame Technologies is an AI digital imaging technology firm that develops solutions for real-world AI challenges, focusing on image processing and embedded sensing platforms. Established in 2016 and headquartered in Silicon Valley and Shanghai, the company specializes in creating algorithms for applications in smartphones, autonomous driving, and consumer electronics. It undertakes core research and development functions, including algorithm development, ASIC design, and software systems, supported by a team with extensive industry experience. Black Sesame is committed to scientific and technological innovation, emphasizing quality and integrity in its services. The firm also designs automotive-grade system-on-chip (SoC) solutions, including the Huashan Series for high computing power and the Wudang Series for cross-domain applications, aiming to advance the future of mobility through its technology.
Mancando is an automotive parts supplier based in Guangzhou, Guangdong, China, founded in August 2015. The company specializes in providing a comprehensive range of car wearing parts for auto repair factories. Its product portfolio includes essential components related to lubrication, braking, wiper systems, filtering, ignition, timing, and lighting, allowing customers to source all necessary automotive products from a single provider. Mancando employs an innovative approach to traditional auto parts management by integrating internet and platform management, enhancing the efficiency and accessibility of automotive parts for its clientele.
Tenry Pharmaceutical
Series B in 2019
Shanghai Tenry Pharmaceutical Company Limited (Tenry) is a modern pharmaceutical enterprise based in Shanghai, specializing in the development and production of biopharmaceuticals, pharmaceutical raw materials, and chemical drugs. The company operates two advanced manufacturing plants and has achieved approval for 73 national drugs, including two biological agents. Tenry's primary focus includes research and development, sales and marketing, and regulatory compliance, allowing it to provide innovative treatments for patients. Its leading products address critical needs in bleeding management and wound management, positioning Tenry as a significant player in the pharmaceutical industry.
Shanghai Cell Therapy Group
Series C in 2018
Shanghai Cell Therapy Group Co., Ltd. is a leading entity in the healthcare sector, specializing in cell therapy technology since its establishment in 2013 in Shanghai, China. The company provides a comprehensive range of services, including technical consulting, technology transfer, and investment in the field of cell therapy. It operates a cellular diagnosis center that integrates cellular research with treatment services, focusing on the development of tumor immune cell therapy. Additionally, Shanghai Cell Therapy Group is engaged in cellular cold storage, the production of cellular pharmaceuticals, antibody research, and facilitating genetic testing for patients, while also supplying valuable research data to cancer facilities.
Safe Medical Evaluation
Series C in 2018
SAFE Pharmaceutical, officially known as Beijing Saifu Medical Research Institute Co., Ltd., operates as a Contract Research Organization (CRO) specializing in pharmaceutical research and development services. The company collaborates with esteemed institutions such as the Shanghai Institute of Materia Medica and the National Drug Safety Evaluation and Research Center, leveraging their expertise to enhance its operational capabilities. With a core team comprised of experienced researchers from prestigious scientific organizations, SAFE Pharmaceutical offers comprehensive services that include R&D consulting, toxicology evaluations, and clinical trial design. This integrated approach allows pharmaceutical developers to efficiently advance their product research and development initiatives, supported by strong technical expertise and management experience in drug development and GLP compliance.
Aohua is a global provider of endoscopy devices and solutions, focused on advancing endoscope technology and enhancing diagnostic and treatment capabilities in endoscopy. Founded in 1994 and based in Shanghai, China, the company specializes in the research, development, production, and sales of electronic endoscope equipment, along with associated diagnostic and surgical consumables. Aohua aims to lead innovation in endoscopic technology, contributing to the overall progress of medical endoscopy practices.
Udesk Ltd. is a customer experience solution provider based in Beijing, China, founded in 2014. The company specializes in omnichannel communication, integrating various platforms to enhance customer interactions across text, mobile, phone, email, chat, and social media. Udesk offers a range of services including digital customer service, customer relationship management, and business intelligence analysis, utilizing artificial intelligence, big data, and cloud computing technologies to optimize marketing and customer success operations. Its solutions encompass call center operations, online customer service, work order systems, and tools such as text and voice robots, agent assistants, and quality inspection services. Udesk serves diverse industries, including healthcare, logistics, retail, education, and banking, with a focus on improving connectivity and responsiveness to ensure customer satisfaction.
Intelligence Indeed
Angel Round in 2018
Intelligence Indeed Co., Ltd. is a technology company based in Shenzhen, China, that specializes in designing and developing intelligent software robots and chatbots aimed at automating enterprise processes. Established in 2018, the company focuses on leveraging artificial intelligence and robotic process automation (RPA) to enhance decision-making and address large-scale, complex challenges faced by businesses and government entities. Intelligence Indeed offers a range of solutions, including finance systems for risk control and account synchronization, communication operations for automated customer service, logistics and shipping tools for cost estimation and information extraction, and digital movement solutions for tasks such as tax management and revenue reconciliation. By combining AI and RPA technology, the company aims to improve operational efficiency and reduce costs across various sectors, including e-commerce and finance.
Harbour BioMed
Series B in 2018
Harbour BioMed is a biotechnology company focused on discovering and developing therapeutics for cancer and inflammatory diseases. Established in 2016 with operations in Shanghai, Cambridge, and Rotterdam, the company leverages its proprietary transgenic mouse platforms to generate fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb), enabling the development of differentiated compounds such as bi-specific and multi-specific antibodies. Harbour BioMed collaborates strategically with various institutions and companies, including The Wistar Institute, WuXi Biologics, and Vir Biotechnology, to advance its pipeline of therapeutics targeting autoimmune diseases, dry eye disease, COVID-19, and other indications.
Gaga Cafe
Series A in 2018
Gaga Café, founded in 2010 and headquartered in Shenzhen, China, operates a high-end café chain primarily in Shenzhen and Shanghai. With a workforce of 600 employees, the company has established a presence with 23 branches, including independent locations and partnerships with bookstores. Gaga Café specializes in offering a menu focused on healthy, green food options, such as fresh fruit tea, brewed coffee, salads, pasta, handmade pizza, and various snacks. The café chain is committed to providing a quality lifestyle experience for its customers and is actively developing new restaurant concepts while collaborating with international food brands. Under the leadership of a professional management team, which includes experts from the food and beverage industry, as well as technology sectors, Gaga Café aims to attract those who appreciate a premium dining experience.
Chemclin
Private Equity Round in 2018
Chemclin Biotech is a Chinese technical service provider specializing in in-vitro diagnostic instruments and auxiliary reagents for clinical diagnosis. The company develops, produces, and sells clinical immunochemiluminescence diagnostic testing reagents and instruments. Its service offerings encompass clinical inspection instruments, various types of auxiliary reagents, technical support, management and certification, as well as the operation of independent medical laboratories. Chemclin is committed to introducing advanced diagnostic products and services to the Chinese market, thereby enhancing the capabilities of clinical diagnostics in the region.
Qeebike Technology Co., Ltd is an electric bike rental and sharing service based in Hangzhou, China, founded in October 2016. The company provides a user-friendly mobile application that enables customers to hire, share, and unlock electric bikes using a QR code. Qeebike offers a fleet equipped with high-capacity, high-performance ternary lithium batteries, which significantly extend battery life compared to typical electric vehicle batteries, thereby reducing operating costs and minimizing the frequency of battery replacements. The bikes feature adjustable pedaling and power modes, along with a temporary parking option, allowing riders to take short breaks while using the service. This combination of features positions Qeebike as an efficient and secure transportation alternative for urban commuters, contributing to its strong order volume and profitability.
Editing and learning (CodePKU)
Series A in 2018
CodePKU Technology (Shenzhen) Co., Ltd. is a prominent provider of programming education and integrated solutions for young learners. Established in 2012 in Shenzhen, China, the company specializes in developing online courses in programming languages such as Scratch and Python, as well as preparing students for the National Olympiad in Informatics in Provinces. CodePKU offers a comprehensive educational experience that includes both online and offline programming instruction, competitions for youth, and international exchange programs. The initiative originated from a student team at the University of Tsukuba, and since its founding, the company has successfully implemented various educational projects, contributing to the growth of programming education for children in China. By combining technology research and development with a robust curriculum and diverse educational services, CodePKU aims to equip young learners with vital skills for the global information age.
Spacety, established in 2016 and headquartered in Changsha, China, is a microsatellite company specializing in developing and launching commercial micro and nano-satellites. It offers rapid, cost-effective, and comprehensive services to scientists, research institutions, and businesses for scientific experiments and technology demonstrations. As of now, Spacety has successfully launched four commercial microsatellites, with plans for more in the future.
Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company focuses on developing solutions that aid physicians in making objective diagnoses through machine learning technology. Lunit's expertise encompasses various medical imaging fields, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. The company's products include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which provides AI-powered biomarkers for immuno-oncology. Lunit aims to enhance clinical decision-making by leveraging data-driven imaging biomarker technology, ultimately improving the accuracy and efficiency of cancer care. The effectiveness of Lunit's deep learning technology has been validated through its recognition in major image recognition competitions, showcasing its capacity to process complex medical imaging data.
Aikucun is a sales distribution company that provides fast and controllable inventory sales channels. As the micro-business purchasing channels have a certain privacy, completely independent of the traditional sales channels, and will not affect the brand's existing sales system. The brand owner can easily complete the inventory sales simply by sharing the inventory. Founded in 2017 by Shanghai Zhongdan Information Technology Co., Ltd., Aikucun is a crowdsourcing distribution platform.
Zongmu Technology Co. Ltd, established in 2013, is a Shanghai-based company specializing in automotive industry solutions and integration services. It operates research and development centers in Beijing and Shenzhen. Zongmu is renowned for its SurroundView ADAS (Advanced Driving Assistance System), which has been successfully implemented in major OEM automotive markets. The company has formed strategic partnerships with several OEM car manufacturers and tier-1 suppliers, solidifying its position as the leading SurroundView ADAS solution provider in the Chinese domestic market.
Enjoy Dental Clinic
Series B in 2018
Enjoy Dental Clinic is a prominent dental care provider established in 2007 and headquartered in Beijing, China. This large-scale dental chain integrates medical treatment with scientific research, education, and administrative functions. The clinic is committed to standardized practices for oral safety, utilizing a four-hand operation model and a rigorous "one person, one machine" aseptic disinfection protocol. Enjoy Dental Clinic employs advanced technologies, including 3D printing, digital-guided dental implants, ultra-thin cosmetic dentistry, and oral digital CT scanning, which enhance treatment efficacy and patient satisfaction. Additionally, the clinic offers franchising services, providing aspiring dentists with professional training and practical experience in clinic management.
JollyChic
Series C in 2018
JollyChic is a comprehensive e-commerce platform founded in 2012 by Aaron Li, headquartered in China. It specializes in the online retail of a diverse range of consumer products, including clothing, accessories, electronics, home goods, baby products, and more. The platform aims to provide customers with a variety of quality and stylish items, catering to various needs and preferences. By facilitating cross-border transactions, JollyChic enables shoppers to access suitable offers while ensuring decent quality in the products available for purchase.
Uoko.com, operated by Sichuan UOKO Investment Management Co. Ltd., is an online property leasing platform based in Chengdu, China, founded in 2012. The platform specializes in apartment rental services, targeting young students and professionals in second-tier cities like Chengdu and Wuhan. Uoko.com offers standardized long-term rental apartments while also providing comprehensive property management solutions for homeowners. These services include post-rental offerings such as cleaning, maintenance, and renovation, enabling homeowners to effectively monetize their vacant properties. By focusing on high-quality rental options and community-oriented after-sales services, Uoko.com aims to meet the needs of urban rental groups and enhance the overall rental experience.
Innovent Biologics
Series E in 2018
Innovent Biologics, Inc. is a prominent biopharmaceutical company based in Suzhou, China, specializing in the discovery, development, manufacturing, and commercialization of monoclonal antibodies. The company focuses on therapeutic areas such as oncology, ophthalmology, immunology, and metabolic diseases. Its flagship product, Tyvyt (sintilimab), is an anti-PD-1 monoclonal antibody approved for treating various cancers, including Hodgkin's lymphoma and esophageal carcinoma. Innovent's pipeline includes several important candidates, such as IBI-301, a rituximab biosimilar for non-Hodgkin's lymphoma, and IBI-303, an adalimumab biosimilar for autoimmune diseases. The company is also developing innovative therapies for conditions like hypercholesterolemia and various cancers. With a robust portfolio of commercialized products and ongoing strategic collaborations with major pharmaceutical companies, Innovent aims to expand its impact in the global biopharmaceutical landscape. Founded in 2011, Innovent is recognized as one of China's leading biotechnology firms.
Yosemite Clinic
Series A in 2018
Yosemite Clinic is a comprehensive medical facility located in Central Pudong, Shanghai, offering a wide range of walk-in medical services. The clinic specializes in various fields, including family and internal medicine, surgery, orthopedics, dermatology, medical cosmetology, dentistry, gynecology, pediatrics, ophthalmology, and rehabilitation medicine. Equipped with advanced technology, Yosemite Clinic features state-of-the-art facilities such as CT, X-ray, ultrasound, and operating rooms, ensuring high-quality care. The clinic's diverse team of medical professionals, hailing from both China and around the globe, allows it to provide services in multiple languages, including English, Japanese, Malay, Mandarin Chinese, and Cantonese. By combining a multidisciplinary approach with modern medical practices, Yosemite Clinic aims to meet the diverse healthcare needs of its patients effectively.
Youdao, Inc. is an internet technology company based in Hangzhou, China, dedicated to providing online services focused on content, community, communication, and commerce. Founded in 2006, the company specializes in developing learning content, applications, and solutions tailored for a diverse range of users, including preschoolers, K-12 students, college students, and adult learners. Its offerings include the Youdao Dictionary, Youdao Cloudnote, and various online dictionary and translation tools. The company also markets smart devices such as the Youdao Smart Pen and Youdao Pocket Translator. Youdao's primary revenue source comes from its Learning services segment, which encompasses online courses like Youdao Premium Courses and NetEase Cloud Classroom. Additionally, the company provides online marketing services and technical support, operating as a subsidiary of NetEase, Inc.
Beijing DeepWise Science And Technology Co., Ltd. is a company that specializes in developing artificial intelligence-based medical application software aimed at enhancing clinical imaging analysis and diagnostics. Founded in 2017 and located in Beijing, China, DeepWise focuses on early screening and diagnosis of various malignant diseases, including lung and breast cancers. Its AI-driven software improves efficiency and diagnostic accuracy in healthcare, offering solutions to hospitals, medical centers, and imaging centers. The company's technology supports the online reading and consultation of medical images, leveraging big data in the cloud to facilitate timely and accurate disease detection and treatment.
Qeebike Technology Co., Ltd is an electric bike rental and sharing service based in Hangzhou, China, founded in October 2016. The company provides a user-friendly mobile application that enables customers to hire, share, and unlock electric bikes using a QR code. Qeebike offers a fleet equipped with high-capacity, high-performance ternary lithium batteries, which significantly extend battery life compared to typical electric vehicle batteries, thereby reducing operating costs and minimizing the frequency of battery replacements. The bikes feature adjustable pedaling and power modes, along with a temporary parking option, allowing riders to take short breaks while using the service. This combination of features positions Qeebike as an efficient and secure transportation alternative for urban commuters, contributing to its strong order volume and profitability.
INXX is an online retail platform that specializes in fashionable clothing, catering to fashion leaders, artists, and designers. The company focuses on high-end professional sportswear and aims to create a vibrant hub for streetwear culture in China. By bringing together local and international fashion brands, INXX provides consumers with access to a diverse range of high-quality fashion products. This platform not only promotes streetwear culture but also fosters collaboration among artists, designers, and art toy creators from various fields, establishing a trendy area for fashion enthusiasts. Through its innovative approach, INXX enhances the shopping experience by efficiently connecting clients with sought-after fashion goods.
Muniu Technology
Series A in 2018
Muniu Technology is a Beijing-based developer specializing in advanced millimeter-wave radar technology. The company focuses on creating radar sensor systems that enhance precision measurement capabilities for various applications, including drones, automobiles, security, and smart home solutions. Muniu Technology's product offerings encompass long-distance data processors, GPS units, landing motion sensors, and ultra long-distance data receptors, which are designed to provide robust radar technological support to industrial clients. Through its innovative sensor and smart control solutions, Muniu Technology aims to advance the integration of radar technology in diverse sectors, enhancing safety and operational efficiency.
Harbour BioMed
Series A in 2018
Harbour BioMed is a biotechnology company focused on discovering and developing therapeutics for cancer and inflammatory diseases. Established in 2016 with operations in Shanghai, Cambridge, and Rotterdam, the company leverages its proprietary transgenic mouse platforms to generate fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb), enabling the development of differentiated compounds such as bi-specific and multi-specific antibodies. Harbour BioMed collaborates strategically with various institutions and companies, including The Wistar Institute, WuXi Biologics, and Vir Biotechnology, to advance its pipeline of therapeutics targeting autoimmune diseases, dry eye disease, COVID-19, and other indications.
Pony.ai, Inc. is a technology company specializing in autonomous driving solutions and artificial intelligence software for automated vehicle manufacturing. Founded in 2016 and headquartered in Fremont, California, with additional offices in San Francisco and China, Pony.ai develops systems that utilize machine learning to navigate vehicles across diverse driving conditions. The company's technology focuses on accurately perceiving the vehicle's environment and predicting driver actions to enhance safety and functionality. In addition to its core development efforts, Pony.ai also operates a public-facing Robotaxi service, showcasing its advancements in autonomous mobility. Through collaborations with automotive manufacturers, Pony.ai aims to integrate its innovative technology into commercial vehicles, significantly contributing to the evolution of transportation.
Hongliyu Cinema
Series B in 2018
Hongliyu Cinema is a Chinese rural cinema operator that specializes in managing and operating a network of local cinemas. The company provides comprehensive cinema management and operation services, with a strong emphasis on theater investment and professional training. In addition to its operational focus, Hongliyu Cinema engages in film and television production, as well as advertising services. Its mission is to enhance the efficiency of theater operations and improve digital media services, ultimately contributing to the growth and development of cinema in rural areas of China.
Berry Oncology
Series A in 2018
Berry Oncology specializes in developing genetic diagnostic solutions for early detection and mid-to-late stage monitoring of various malignant tumors. Their offerings span from companion diagnostics to response monitoring and prognosis prediction for both targeted and immune therapies, aiming to enhance cancer prevention and tumor diagnosis globally. The company's primary mission is to facilitate early diagnosis and treatment of all tumors, ensuring precise care for patients. Berry Oncology aspires to become a global leader in early screening and diagnosis of tumors, particularly in China's tumor gene testing market.
Yunji is a documentary film production company in China.
Yanwen Express
Series B in 2017
Beijing Yanwen Logistics Co., Ltd, established in 1998 and headquartered in Beijing, China, is a specialized logistics company providing freight forwarding and logistics services. The company focuses on serving e-commerce businesses by offering tailored international logistics solutions. Yanwen is equipped to handle a wide range of shipments, from small packages to larger goods, utilizing various modes of transportation including aircraft, trains, and automobiles. The firm emphasizes professional transport management to meet the diverse needs of its customers, supported by approvals from relevant government departments.
Ayshealth Technology
Series A in 2017
Ayshealth Technology, founded in 2014 and based in Beijing, China, specializes in developing chronic disease management systems. The company offers a guideline-based decision support (GDS) platform that utilizes artificial intelligence technologies to assist healthcare providers in diagnosing and treating chronic diseases. This cloud-based service enables physicians, patients, hospital administrators, government agencies, and insurance companies to effectively monitor and manage health data related to chronic conditions. By providing data analytics and professional medical support, Ayshealth Technology enhances decision-making capabilities for doctors and facilitates comprehensive patient care.